Vimal ad featuring top Bollywood stars draws FDA notices
FDA notices tied to a Vimal advertisement featuring Shah Rukh Khan, Ajay Devgn and Tiger Shroff signal heightened scrutiny of consumer-brand advertising and celebrity endorsements in India.
What happened
India’s FDA issued notices connected to a Vimal advertisement featuring Shah Rukh Khan, Ajay Devgn and Tiger Shroff, highlighting regulatory scrutiny of
Why this matters
Treat advertising-compliance controls and endorsement-related liabilities as priority diligence areas in FMCG partnership or acquisition targets.
What to watch
- Details of the FDA notice, including alleged violations, response deadline and whether products, claims or endorsement practices are named.
- Any coordinated action by FSSAI, state FDAs, ASCI, the Ministry of Information and Broadcasting or consumer courts.
- Campaign withdrawal, disclaimer changes, public response or legal challenge from Vimal or the featured celebrities.
- Broadcaster, OTT, social-platform or cinema restrictions on the advertisement.
- Notices against other pan masala, mouth freshener, tobacco-adjacent or celebrity-endorsed FMCG brands.
- Evidence of fines, product restrictions or precedent-setting court orders.
- Audit celebrity-led campaigns for health, safety, product-category and surrogate-branding claims before renewal or media release.
- Build documented substantiation files and approval trails for all consumer-facing claims, visuals and disclaimers.
- Prepare alternative creative and media plans in case broadcasters, platforms or cinemas pause the campaign.
- Review endorsement contracts for morality, regulatory-cooperation, takedown and reputational-risk clauses.
- Monitor whether competitors reduce celebrity association with pan masala, mouth freshener or adjacent categories.